Original Research
Accepted on 27 Feb 2026
Frailty, Nutritional Status, and Inflammation as Determinants of Chemotherapy Delivery and Outcomes in Pancreatic Cancer Patients Receiving Gemcitabine Plus Nab-Paclitaxel
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers